Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,224.48
(
0.28%
)
News Focus
News Focus
Post# of 257627
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 185242

Wednesday, 07/01/2015 5:02:08 PM

Wednesday, July 01, 2015 5:02:08 PM

Post# of 257627
GILD submits NDA for TAF/Emtiva/Edurant FDC*, using priority-review voucher:

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=2064274

See #msg-109435833 for info on the two GILD-JNJ collaborations in HIV.

*GILD refers to this FDC as “R/F/TAF.”

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today